Qube Research & Technologies (QRT)’s BioAge Labs BIOA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.43M	Buy	+483,993	New	+$6.71M	﹤0.01%	2030

Other funds holding BIOA

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Cosmic Management West Hollywood, California $327M AUM 21.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BIOA Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in BioAge Labs (BIOA) in Q3 2026: 483,993 shares worth $3.43M. The stake represents ﹤0.01% of the portfolio and ranks #2030 among its holdings.

82 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

Qube Research & Technologies (QRT) held 483,993 shares of BioAge Labs worth $3.43M as of Q3 2026.
BioAge Labs was a new Qube Research & Technologies (QRT) position in Q3 2026.
BioAge Labs made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2030 holding.
82 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.